GlobeNewswire Inc.··Pomerantz LlpAquestive Stock Tanks 37% on FDA Deficiency Letter; Class Action Lawsuit Filed
Pomerantz Law Firm filed securities fraud lawsuit against $AQST after FDA rejected Anaphylm NDA, triggering 37% stock drop. Investor deadline May 4.
EOSEAQSTNKTRsecurities fraudclass action lawsuit